Previous 10 | Next 10 |
Medtronic's share price has declined by over 15% over the last six months. The company's P/E is below 18. The company is reliable and growing even with higher uncertainty. For further details see: Medtronic Is That 'Boring' And Reliable Stock Your Portfolio Needs
Shares of Becton Dickinson and Company (NYSE:BDX) traded at a new 52-week high today of $273.14. Approximately 178,000 shares have changed hands today, as compared to an average 30-day volume of 1.4 million shares. Over the past year, Becton Dickinson and Company has traded in a range of...
BD Collaborates with ReturnSafe to Help Employers Manage COVID-19 Testing Organizations including Superhuman Use BD Veritor™ At-Home COVID-19 Test with the ReturnSafe Platform to Keep Employees Safe at Work PR Newswire FRANKLIN LAKES, N.J. , Feb. 8, 2022...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Investors are growing tired of the ongoing volatility in the stock market, but unfortunately, Thursday's activity on Wall Street didn't suggest the ups and downs would end anytime soon. As of 1 p.m. ET, the Dow Jones Industrial Average (DJINDICES: ^DJI) was down 328 points to 35,302...
Becton, Dickinson and Company (BDX) Q1 2022 Earnings Conference Call February 03, 2022, 08:30 ET Company Participants Francesca DeMartino - SVP, IR Thomas Polen - President, CEO & Chairman Christopher DelOrefice - EVP & CFO Simon Campion - EVP & President, Interventional Segment C...
The following slide deck was published by Becton, Dickinson and Company in conjunction with their 2022 Q1 earnings call. For further details see: Becton, Dickinson and Company 2022 Q1 - Results - Earnings Call Presentation
Becton Dickinson and Company (NYSE:BDX) traded at a new 52-week high today of $269.30. So far today approximately 682,000 shares have been exchanged, as compared to an average 30-day volume of 1.3 million shares. In the past 52 weeks, Becton Dickinson and Company share prices are bracket...
Shares of Becton, Dickinson (BDX +4.4%) are up in morning trading after the company raised its FY 2022 guidance. Becton, Dickinson now expects adjusted diluted EPS for the fiscal year to be between $12.80 and $13.00, compared to $12.30-$12.50 before. The company also had an extremely str...
Becton, Dickinson press release (NYSE:BDX): Q1 Non-GAAP EPS of $3.64 beats by $0.79. Revenue of $5B (-6.0% Y/Y) beats by $240M. The company raised its full year revenue and adjusted EPS guidance. The company now expects fiscal year 2022 revenues to be in the range of $19.55 billion to $...
News, Short Squeeze, Breakout and More Instantly...
Becton Dickinson and Company Company Name:
BDX Stock Symbol:
NYSE Market:
Becton Dickinson and Company Website:
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases PR Newswire Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J. , July 25, 20...
2024-07-11 12:00:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:C...
BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials PR Newswire Company Committed to Support Global Health and Customers BD Taking all Available Measures to Mitigate Supplier Issue FRANKLIN LAKES, N.J. , July 10 , 2024...